This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions
Protein substance: HER2 (ErbB2) — the target protein referenced by Trastuzumab
{
"resourceType" : "SubstanceDefinition",
"id" : "her2",
"identifier" : [{
"system" : "https://www.uniprot.org",
"value" : "P04626"
}],
"status" : {
"coding" : [{
"system" : "http://hl7.org/fhir/publication-status",
"code" : "active",
"display" : "Active"
}]
},
"classification" : [{
"coding" : [{
"system" : "http://example.europa.eu/fhir/SubstanceType",
"code" : "protein",
"display" : "Protein"
}]
}],
"domain" : {
"coding" : [{
"system" : "http://example.europa.eu/fhir/Domain",
"code" : "human",
"display" : "Human use"
}]
},
"description" : "Human HER2 (ErbB2, receptor tyrosine-protein kinase erbB-2). A transmembrane receptor of the EGFR family, frequently overexpressed in breast and gastric cancers. The molecular target of trastuzumab and other HER2-directed therapies.",
"code" : [{
"code" : {
"coding" : [{
"system" : "https://www.uniprot.org",
"code" : "P04626",
"display" : "ERBB2_HUMAN"
}]
}
}],
"name" : [{
"name" : "Receptor tyrosine-protein kinase erbB-2",
"preferred" : true,
"language" : [{
"coding" : [{
"system" : "urn:ietf:bcp:47",
"code" : "en",
"display" : "English"
}]
}]
},
{
"name" : "HER2",
"preferred" : false
},
{
"name" : "ErbB-2",
"preferred" : false
},
{
"name" : "CD340",
"preferred" : false
}],
"protein" : {
"sequenceType" : {
"coding" : [{
"system" : "http://hl7.org/fhir/substance-sequence-type",
"code" : "complete",
"display" : "Complete"
}]
},
"numberOfSubunits" : 1,
"subunit" : [{
"subunit" : 1,
"length" : 1255
}],
"gene" : [{
"sequenceOrigin" : {
"coding" : [{
"system" : "http://hl7.org/fhir/gene-sequence-origin",
"code" : "human",
"display" : "Human"
}]
},
"gene" : {
"concept" : {
"coding" : [{
"system" : "http://www.genenames.org",
"code" : "ERBB2",
"display" : "Erb-B2 receptor tyrosine kinase 2"
}]
}
}
}]
}
}
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.